Hospital Hyperglycemia in Prediabetic Patients Converts into Clinical Diabetes within Just One Month: Study Finds
A recent prospective 4-week follow-up study found that hospital hyperglycemia in prediabetic patients is a critical prognostic red flag associated with an 8% short-term mortality rate and an 8.7% risk of transitioning to clinical diabetes within just one month, as detailed in the Journal of The Association of Physicians of India in March 2026.
While stress-induced hyperglycemia is a documented response to acute physiological injury in up to one-third of critical care cases, the specific metabolic profile and longitudinal outcomes of "hospital hyperglycemia" remain poorly defined in clinical literature. Addressing this knowledge gap, Dr Apoorv Ojha and colleagues from the Department of Medicine at Lady Hardinge Medical College, New Delhi, conducted this investigation to characterize the clinical features and immediate post-discharge outcomes of patients presenting with elevated in-hospital glucose levels.
Therefore, the prospective 4-week follow-up study analyzed 50 adult patients at a tertiary care facility in India who presented with Random Blood Sugar (RBS) exceeding 140 mg/dL, excluding those with Type 1 Diabetes Mellitus (T1DM) or severe anemia. The research team employed Glycated Hemoglobin (HbA1c) at admission and an Oral Glucose Tolerance Test (OGTT) at the four-week mark to evaluate primary endpoints, including mortality rates, duration of hospital stay, and metabolic status.
Key Clinical Findings of the Study Include:
• Undiagnosed Prevalence: The study revealed that 26% of patients presenting with hospital hyperglycemia were actually living with unrecognized diabetes at the time of admission.
• Mortality Burden: Notably, an 8% mortality rate was observed exclusively within the prediabetes cohort, contrasting with zero deaths in the normoglycemic or previously diagnosed groups.
• Rapid Progression: Short-term metabolic tracking indicated that 8.7% of prediabetic subjects progressed to a formal Type 2 Diabetes Mellitus (T2DM) diagnosis within 28 days.
• Morbidity Correlations: Increased Body Mass Index (BMI) of 25.63 kg/m² and higher HbA1c levels were positively associated with extended hospital stays compared to normoglycemic individuals.
The results suggest that hospital hyperglycemia serves as a potent biochemical predictor for future diabetic risk, with nearly half of the hyperglycemic patients identified as having either undiagnosed diabetes or prediabetes upon admission. Furthermore, the data indicates that recent-onset elevations in glucose are linked to heightened short-term mortality, particularly when protective cellular mechanisms against hyperglycemia are absent.
Thus, the study concludes clinicians should consider implementing thorough investigations and a minimum four-week follow-up period for any patient presenting with elevated in-hospital glucose levels to ensure early detection and management of underlying glycemic disorders.
The findings are tempered by a relatively small patient sample and non-uniform data distribution, suggesting that future research utilizing larger cohorts and standardized criteria is necessary to more accurately project the prevalence of undiagnosed diabetes in this population.
Reference
Ojha A, Aggarwal R, Prakash A, et al. Hospital Hyperglycemia is Associated with Adverse Short-term Metabolic and Mortality Outcomes. J Assoc Physicians India 2026;74(3):59–61.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.